Latest Articles

‘First-of-a-kind’ daily pill for endometriosis treatment approved for NHS in England - Inkl

‘First-of-a-kind’ daily pill for endometriosis treatment approved for NHS in England Inkl

New pill to transform treatment of endometriosis approved on the NHS - Ludlow Advertiser

New pill to transform treatment of endometriosis approved on the NHS Ludlow Advertiser

New pill to transform treatment of endometriosis approved on the NHS - The Independent

New pill to transform treatment of endometriosis approved on the NHS The Independent

New pill to transform treatment of endometriosis approved on the NHS - Express & Star

New pill to transform treatment of endometriosis approved on the NHS Express & Star

New pill to transform treatment of endometriosis approved on the NHS - The Irish News

New pill to transform treatment of endometriosis approved on the NHS The Irish News

‘First-of-a-kind’ daily pill for endometriosis treatment approved for NHS in England - The Guardian

‘First-of-a-kind’ daily pill for endometriosis treatment approved for NHS in England The Guardian

First daily pill for endometriosis approved for NHS use - NICE

First daily pill for endometriosis approved for NHS use NICE

Endometriosis: First combination pill for treating symptoms to be rolled out in NHS.

Association Between Levonorgestrel-Releasing Intrauterine System Exposure Duration and Breast Cancer Incidence.

To investigate the association between the duration of levonorgestrel-releasing intrauterine system (LNG-IUS) use and breast cancer risk in Korean women.

Dydrogesterone is an eligible tool to suppress LH surge in assisted reproduction technologies (ART) cycles.

To evaluate Dydrogesterone's effectiveness in PPOS protocols for IVF/ICSI or oocyte cryopreservation, focusing on LH surge suppression and metaphase II oocyte yield.